Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    Open Studies | "Erythroblastosis, Fetal"
Show Display Options
Rank Status Study
1 Recruiting Determining Prevalence of Acute Bilirubin Encephalopathy in Developing Countries
Conditions: Demonstrate BIND II Score of >=5, is Valid for Detecting Moderate to Severe ABE in Neonates <14 Days Old.;   Demonstrate Community-BIND Instrument, a Modified BIND II, is a Valid and Reliable Tool for Detecting ABE.;   Demonstrate That Community-BIND Can be Used for Acquiring Population-based Prevalence of ABE in the Community.
Intervention: Other: Bilirubin Induced Neurologic Dysfunction II score

Indicates status has not been verified in more than two years